Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1954 1
1955 1
1956 1
1958 1
1959 1
1960 1
1961 1
1962 3
1963 4
1964 1
1965 1
1967 1
1968 1
1969 1
1971 2
1972 3
1973 2
1974 3
1975 4
1976 13
1977 7
1978 6
1979 14
1980 6
1981 6
1982 2
1983 2
1984 5
1985 7
1986 5
1987 6
1988 9
1989 8
1990 12
1991 14
1992 13
1993 14
1994 14
1995 11
1996 14
1997 10
1998 13
1999 14
2000 15
2001 10
2002 8
2003 19
2004 19
2005 18
2006 34
2007 23
2008 14
2009 24
2010 23
2011 22
2012 35
2013 30
2014 35
2015 29
2016 29
2017 25
2018 28
2019 21
2020 32
2021 39
2022 33
2023 28
2024 10

Text availability

Article attribute

Article type

Publication date

Search Results

795 results

Results by year

Filters applied: . Clear all
Page 1
Cyclopentolate.
[No authors listed] [No authors listed] 2021 Apr 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2021 Apr 19. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000724 Free Books & Documents. Review.
No information is available on the use of cyclopentolate during breastfeeding. Anticholinergic drugs might interfere with breastfeeding. A single dose of ophthalmic cyclopentolate is not likely to interfere with breastfeeding; however, during long-term use, observe …
No information is available on the use of cyclopentolate during breastfeeding. Anticholinergic drugs might interfere with breastfeedi …
Ocular Cyclopentolate: A Mini Review Concerning Its Benefits and Risks.
Contreras-Salinas H, Orozco-Ceja V, Romero-López MS, Barajas-Virgen MY, Baiza-Durán LM, Rodríguez-Herrera LY. Contreras-Salinas H, et al. Clin Ophthalmol. 2022 Nov 15;16:3753-3762. doi: 10.2147/OPTH.S388982. eCollection 2022. Clin Ophthalmol. 2022. PMID: 36411874 Free PMC article. Review.
Cycloplegic and mydriatic agents are essential in ophthalmological clinical practice since they provide the means for diagnosing and treating certain eye conditions. In addition, cyclopentolate has proven to possess certain benefits compared to other available cycloplegics …
Cycloplegic and mydriatic agents are essential in ophthalmological clinical practice since they provide the means for diagnosing and treatin …
Topical Cyclopentolate-Induced Systemic Toxicity.
Gunasekaran P, Choudhary B, Diwakar A, Saini L. Gunasekaran P, et al. Indian Pediatr. 2023 Dec 15;60(12):1045-1046. Indian Pediatr. 2023. PMID: 38087795 Free article. No abstract available.
Comparison of cyclopentolate versus tropicamide cycloplegia: A systematic review and meta-analysis.
Yazdani N, Sadeghi R, Momeni-Moghaddam H, Zarifmahmoudi L, Ehsaei A. Yazdani N, et al. J Optom. 2018 Jul-Sep;11(3):135-143. doi: 10.1016/j.optom.2017.09.001. Epub 2017 Nov 11. J Optom. 2018. PMID: 29132914 Free PMC article. Review.
PURPOSE: The aim of the present meta-analysis is to compare the efficacy of cyclopentolate and tropicamide in controlling accommodation during refraction. METHODS: A comprehensive literature search was performed in PubMed, Scopus, Science direct and Ovid databases by the k …
PURPOSE: The aim of the present meta-analysis is to compare the efficacy of cyclopentolate and tropicamide in controlling accommodati …
Cyclopentolate eye drops-induced anaphylaxis in an infant.
Terece SP, Ertoy-Karagöl Hİ, Köken G, Atalay HT, Türkcan BT, Vural Ö, Bakırtaş A. Terece SP, et al. Turk J Pediatr. 2022;64(5):915-918. doi: 10.24953/turkjped.2022.125. Turk J Pediatr. 2022. PMID: 36305442 Free article.
CONCLUSIONS: In children, hypersensitivity reactions due to cyclopentolate are very rare. Only four pediatric patients were reported in the literature to have developed an allergic reaction after the administration of cyclopentolate eye drops. We present here the yo …
CONCLUSIONS: In children, hypersensitivity reactions due to cyclopentolate are very rare. Only four pediatric patients were reported …
Comparisons of atropine versus cyclopentolate cycloplegia in myopic children.
Ye L, Li S, Shi Y, Yin Y, He J, Zhu J, Xu X. Ye L, et al. Clin Exp Optom. 2021 Mar;104(2):143-150. doi: 10.1111/cxo.13128. Clin Exp Optom. 2021. PMID: 32844483 Free article. Clinical Trial.
CLINICAL RELEVANCE: In clinical practice, 1% atropine and 1% cyclopentolate are used as cycloplegia agents to diagnose refractive error. The influence of 1% atropine on ocular biometry is obscure, and the impact of 1% cyclopentolate remains controversial. BACKGROUND …
CLINICAL RELEVANCE: In clinical practice, 1% atropine and 1% cyclopentolate are used as cycloplegia agents to diagnose refractive err …
SIDE-EFFECTS OF CYCLOPENTOLATE.
SIMISTER JM. SIMISTER JM. Br Med J. 1963 Dec 14;2(5371):1536. doi: 10.1136/bmj.2.5371.1536. Br Med J. 1963. PMID: 14063099 Free PMC article. No abstract available.
1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response.
Manny RE, Fern KD, Zervas HJ, Cline GE, Scott SK, White JM, Pass AF. Manny RE, et al. Optom Vis Sci. 1993 Aug;70(8):651-65. doi: 10.1097/00006324-199308000-00013. Optom Vis Sci. 1993. PMID: 8414387 Review.
The time course of cycloplegia was measured by monitoring residual accommodation after the application of 1 drop (29.3 microliters) of 1% cyclopentolate hydrochloride. Three different measures of residual accommodation were made, one objective assessment with an optometer, …
The time course of cycloplegia was measured by monitoring residual accommodation after the application of 1 drop (29.3 microliters) of 1% …
Interventions to slow progression of myopia in children.
Walline JJ, Lindsley KB, Vedula SS, Cotter SA, Mutti DO, Ng SM, Twelker JD. Walline JJ, et al. Cochrane Database Syst Rev. 2020 Jan 13;1(1):CD004916. doi: 10.1002/14651858.CD004916.pub4. Cochrane Database Syst Rev. 2020. PMID: 31930781 Free PMC article.
Pharmaceutical agents: at one year, children receiving atropine eye drops (3 studies; n = 629), pirenzepine gel (2 studies; n = 326), or cyclopentolate eye drops (1 study; n = 64) showed significantly less myopic progression compared with children receiving placebo: MD 1.0 …
Pharmaceutical agents: at one year, children receiving atropine eye drops (3 studies; n = 629), pirenzepine gel (2 studies; n = 326), or …
Viscous cyclopentolate.
Miller R, Searle C. Miller R, et al. Aust N Z J Ophthalmol. 1990 Nov;18(4):437-8. doi: 10.1111/j.1442-9071.1990.tb01832.x. Aust N Z J Ophthalmol. 1990. PMID: 2076295 Clinical Trial. No abstract available.
795 results